Learn More
Gibco™ Human LIF Recombinant Protein
Description
Reconstitution: Centrifuge the vial briefly, before opening to bring the contents to the bottom. Reconstitute the lyophilized protein in sterile, distilled water or appropriate buffered solution containing 0.1% BSA to regain full activity. Apportion there constituted protein into working aliquots and store at -20°C. Make any further dilutions of the reconstituted protein in buffered solution containing a carrier protein, such as PBS with 0.1% BSA. Storage: Store the lyophilized protein at 2-8°C, preferably desiccated. Upon reconstitution, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles.
Specifications
Specifications
| Número de acceso | P15018 |
| Para utilizar con (aplicación) | Control, ELISA, Functional Assay, Immunohistochemistry, Western Blot |
| Formulación | protein with no preservative |
| ID de gen (Entrez) | 3976 |
| Peso molecular | 21 kDa |
| Nombre | Human LIF |
| Método de purificación | Sequential Chromatography |
| Cantidad | 10 μg |
| Concentración de endotoxinas | <0.1 ng/μg |
| Alias de gen | CDF; cholinergic differentiation factor; cholinergic neuronal differentiation factor; d factor; DIA; differentiation inhibitory activity; differentiation-inducing factor; differentiation-stimulating factor; Emfilermin; hepatocyte-stimulating factor III; HILDA; human interleukin in DA cells; leukemia inhibitory factor; leukemia inhibitory factor (cholinergic differentiation factor); LIF; Melanoma-derived LPL inhibitor; MLPLI; myeloid leukaemia inhibitory factor |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.